Crinetics Pharmaceuticals CRNX
NASDAQ CRNX
$84.95 +0.00 (+0.00%)
At close: Sep 2, 2026 · 4:00 PM EDT

Crinetics Pharmaceuticals (CRNX) Work In Process (2025 - 2026)

Crinetics Pharmaceuticals (CRNX) posted quarterly Work In Process of $3.0 million for Q1 2026, up 51.45% quarter-over-quarter from $2.0 million in Q4 2025.

Analysis

Crinetics Pharmaceuticals (CRNX) Work In Process (2025 - 2026) Analysis & Trends

Crinetics Pharmaceuticals' Work In Process history runs 2 years deep, the most recent figure standing at $3.0 million for Q1 2026.

  • In Q1 2026, Work In Process changed N/A year-over-year to $3.0 million; the TTM figure through Mar 2026 stood at $3.0 million (changed N/A YoY), while the FY2025 annual figure was $2.0 million, changed N/A from the prior year.
  • Work In Process for Q1 2026 stood at $3.0 million, up from $2.0 million in the prior quarter.
  • The five-year high for Work In Process was $3.0 million in Q1 2026, with the low at $2.0 million in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Crinetics Pharmaceuticals 8.99 Bn 8.99 Bn 24.96 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 2.59 Mn
Mar 31, 2026 3.04 Mn
Dec 31, 2025 2.00 Mn